SCHEMBL6636083

SCHEMBL6636083

CC(=O)C(N)CC(C)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10641706 0.83 SLC7A5 (0.43) —
SCHEMBL14508101 0.81 — —
SCHEMBL23979315 0.81 — —
SCHEMBL5522530 0.81 — —
SCHEMBL2617107 0.81 — —
SCHEMBL13131507 0.79 — —
Hydrochloric Acid SCHEMBL8777148 0.79 SLC7A5 (0.61) —
SCHEMBL497637 0.79 — —
Hydrochloric Acid SCHEMBL8777147 0.79 SLC7A5 (0.61) —
SCHEMBL25083538 0.79 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160324980-A1 METHODS OF PREPARATION OF CONJUGATES IMMUNOGEN, INC. 2016-11-10 — — US disclosed
EP-1067894-A4 PROTEASE INHIBITORS SMITHKLINE BEECHAM CORP (US) 2004-09-08 — — EP disclosed
EP-1067894-A2 PROTEASE INHIBITORS SmithKline Beecham Corporation (US) 2001-01-17 — — EP disclosed
WO-1999059526-A2 PROTEASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 1999-11-25 — — WO disclosed
Send feedback